FTI
AZN icon

Fiduciary Trust International’s AstraZeneca AZN Stock Holding History

Fiduciary Trust International’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-81,300
Closed -$5.54M – 110
2017
Q2 		$5.54M Buy
+81,300
New +$5.31M 1.43% 14

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fiduciary Trust International's AZN Position: Q2 2020 in Review

Fiduciary Trust International sold out of AstraZeneca (AZN) in Q2 2020, closing a stake of 54,200 shares — an estimated $4.84M sold.

Fiduciary Trust International first reported a position in AZN in Q2 2013 and held it in 27 quarters. The position peaked at $7.25M in Q3 2019. 669 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

  • Fiduciary Trust International reported no remaining AstraZeneca position as of Q2 2020 after selling out during the quarter.
  • Fiduciary Trust International sold 54,200 AstraZeneca shares in Q2 2020, an estimated $4.84M.
  • Fiduciary Trust International first reported a position in AstraZeneca in Q2 2013 and held it in 27 quarters.
  • Fiduciary Trust International's AstraZeneca position peaked at $7.25M in Q3 2019.
  • 669 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on Fiduciary Trust International's 13F filing for Q2 2020, filed 11 Aug 2020.